SEC Form 4 · accession 0000899243-18-018959

EverQuote, Inc. · EVER

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — President and CEO · Director

Period of report

Jun 28, 2018

Accepted (ET)

Jul 2, 2018 · 5:00 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001640428

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Class A Common Stock^F1	Jun 28, 2018	A	640,000	$0.00	A	640,000	D
Class A Common Stock^F2	Jul 2, 2018	C	274,012	$0.00	A	274,012	I	See footnote
Class A Common Stock^F2	Jul 2, 2018	S	274,012	$18.00	D	0	I	See footnote
Class A Common Stock	Jul 2, 2018	C	291,200	$0.00	A	931,200	D
Class A Common Stock	Jul 2, 2018	S	291,200	$18.00	D	640,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F3,F4	—	Jul 2, 2018	C	133,065	D	—	—	Class B Common Stock	1,064,520	0	I
Class B Common Stock^F4,F2	—	Jul 2, 2018	C	1,064,520	A	—	—	Class A Common Stock	1,064,520	1,064,520	I
Class B Common Stock^F4,F2	—	Jul 2, 2018	C	274,012	D	—	—	Class A Common Stock	274,012	790,508	I
Class B Common Stock^F4	—	Jul 2, 2018	C	291,200	D	—	—	Class A Common Stock	291,200	287,904	D

F1Consists of shares of Class A Common Stock issuable under 640,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over seven years with the first installment vested on June 30, 2018.
F2Consists of shares held by Cogo Labs, Inc., with respect to which Cogo Labs, Inc. has empowered Mr. Birnbaum and Mira Wilczek, acting together and not individually, to exercise investment power, which may be revoked by Cogo Labs, Inc. at any time. Mr. Birnbaum disclaims beneficial ownership of the shares owned directly by Cogo Labs, Inc. except to the extent of any pecuniary interest therein.
F3The Series A Preferred Stock converted into Class B Common Stock on a one-for-eight basis automatically upon the closing of the issuer's initial public offering of its Class A Common Stock without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the issuer's initial public offering of its Class A Common Stock. The shares had no expiration date.
F4The Class B Common Stock is convertible into the issuer's Class A Common Stock on a one-for-one basis upon certain transfers of such shares and at the holder's election and has no expiration date.